INS and myotonic dystrophy type 1: In addition, serum leptin and glucagon levels in DM1 patients are pathologically increased [66, 67] Specifically, insulin is a potent activator of SCD1 transcription [68] while leptin was reported to inhibit SCD1 expression [69].